[1]
Li, W. et al. 2026. Emerging Therapeutic Landscapes for KRAS-Mutant Pancreatic Ductal Adenocarcinoma: Beyond the “Undruggable” Paradigm. Turkish Journal of Gastroenterology. 37, 4 (Jan. 2026), 409–419. DOI:https://doi.org/10.5152/tjg.2026.25595.